Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
The patient and local surgical team were located in Gibraltar, about 2,400 kilometers (about 1,500 miles) away. The procedure ...
An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The ...
About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Kishan and colleagues found that men with PSA levels of 0.51-1.00 ng/mL had a reduction in mortality risk with the addition of hormone therapy (HR 0.72, 95% CI 0.54-0.96), as did those with PSA levels ...
Stage and screen actor Robert Lindsay, 76, is the 100,000th signature to the petition calling for prostate cancer screening ...
11d
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results